Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1978 Dec;38(6):737-44.
doi: 10.1038/bjc.1978.281.

Effect of prostaglandins and hormones on cyclic AMP formation in rat hepatomas and liver tissue

Free PMC article

Effect of prostaglandins and hormones on cyclic AMP formation in rat hepatomas and liver tissue

G O Brønstad et al. Br J Cancer. 1978 Dec.
Free PMC article

Abstract

The formation of cyclic AMP was studied in normal liver, subcutaneous hepatomas derived from MH1C1 cells, and premalignant liver and primary hepatomas induced by the carcinogens 2-acetylaminofluorene (AAF) and 4-dimethylamino-azobenzene (DAB). While only very slight effects of prostaglandins (PG) were seen in slices of normal liver, all the hepatomas responded strongly to PGE1 and PGE2. The hepatomas also had increase PGE1-sensitive adenylate-cyclase activity. PGF1alpha and PGF2alpha did not increase the cAMP level significantly either in the liver or in the hepatomas. During AAF carcinogenesis the response to PGE1 increased slightly during the carcinogen feeding, and was greatly elevated only in the fully developed hepatomas. This is in contrast to the increase in adrenalin response seen during carcinogenesis, which starts much earlier, and reaches a peak value within 8--10 weeks. It is concluded that various hepatomas have elevated responsiveness to PGE1 and PGE2 as well as to adrenalin, but the course of change in the tissues' ability to respond to these agents during carcinogenesis is very different.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Biol Chem. 1951 Nov;193(1):265-75 - PubMed
    1. Cancer Res. 1977 Oct;37(10):3599-606 - PubMed
    1. J Cyclic Nucleotide Res. 1977 Jun;3(3):189-98 - PubMed
    1. Physiol Rev. 1976 Oct;56(4):652-708 - PubMed
    1. Cancer Res. 1976 Nov;36(11 Pt. 2):4250-5 - PubMed